Goserelin Teva

Medicinal product

(Invented) name

Goserelin Teva

Active substance (s)

Goserelinas

Strength

10,8 mg

Pharmaceutical form

implantas užpildytame švirkšte

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L02AE03, Goserelin

Marketing authorisation holder

Teva B.V., Nyderlandai

Date of authorisation

2017-07-10

Date of renewal

Documents

4097_1_3 Goserelin Teva PZ 171006.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

PT/H/1637/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Viename implante yra	1 vnt.
Goserelinas	10,8 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
68747	83330	1083330	užpildytas švirkštas	N1		Receptinis	LT/1/17/4097/001	Netiekiama	-	-	No	-	-
68748	83331	1083331	užpildytas švirkštas	N2		Receptinis	LT/1/17/4097/002	Netiekiama	-	-	No	-	-
68749	83332	1083332	užpildytas švirkštas	N3		Receptinis	LT/1/17/4097/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2017-12-05	Išregistruotas
2017-07-10	Registruotas